No recommendation
No news or research item is a personal recommendation to deal. Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views.
(Sharecast News) - Gelion said on Wednesday that it has made progress on commercialisation of its nano-encapsulated sulfur cathode technology, highlighting advances with partners TDK and QinetiQ and an increase in Australian government funding to support scale-up.
The AIM-traded advanced battery materials company, which is seeking to replace strategic minerals in lithium-ion battery cathodes with its sulfur-based 'NES' material, confirmed that samples of its cathode active material had been supplied to TDK Corporation in Japan.
Initial pouch cells incorporating Gelion's NES CAM had been successfully manufactured by TDK, with early test results meeting the company's expectations. Joint development work is ongoing.
Gelion also provided its GEN3 CAM to QinetiQ in the UK, which produced initial pouch cells.
The company was now equipping Gelion Europe to supply NES CAM to QinetiQ to enable production of NES CAM pouch cells.
Management said that represented an important step in executing its partnership-led commercialisation strategy and demonstrates its ability to produce material volumes consistent with pouch cell demonstration requirements.
The group added that active discussions were progressing with multiple global partners across a range of applications and geographies, in line with its strategy to build a diversified portfolio of partnerships with tier-one manufacturers and technology leaders.
Separately, the Australian Renewable Energy Agency had agreed a variation to its funding agreement with Gelion, originally announced in December 2024, increasing the total project budget from around 4.8m to approximately 5.3m.
The additional funding was aimed at accelerating the commercialisation and scale-up of Gelion's sulfur CAM at its Advanced Commercial Prototyping Centre, supporting expanded testing, integration activities and larger sample volumes, as well as global supply chain development and product qualification.
"I am delighted to report that we are executing effectively against the roadmap presented to shareholders in November," said chief executive John Wood.
"The delivery of CAM samples to our partners TDK and QinetiQ, together with the successful manufacture of initial pouch cells by TDK, represents tangible progress toward the commercialisation of our technology.
"We remain focussed on converting our strong pipeline of discussions into formal partnerships and delivering long-term value for shareholders."
Gelion said it expected to publish its unaudited half-year results for the six months ended 31 December on 2 March.
At 1303 GMT, shares in Gelion were up 0.57% at 18.6p.
Reporting by Josh White for Sharecast.com.